Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

DynaCAD urology with advanced annotation UroNav cart with advanced annotation option UroNav with advanced annotation July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for ...

Prostate cancer, a growing concern worldwide, often progresses silently, making early detection crucial. Symptoms like ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone ...

American Idol' host Ryan Seacrest opened up about his father's prostate cancer journey during an emotional broadcast of 'On ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

New Jersey man pleads guilty to leading $600 million catalytic converter theft ring ...

During Monday's episode of On Air with Ryan Seacrest, Ryan Seacrest opened up about his father, Gary Seacrest's, battle with ...

Ryan Seacrest is getting candid. Seacrest, 50, got emotional and teared up during a July 21 broadcast of “On Air With Ryan ...

Vir Biotechnology has a strong cash position and is poised to generate definitive data in antivirals and oncology, making ...

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted ...